麻豆传媒

New York, NY USA

Our 麻豆传媒 on 麻豆传媒
View All >

麻豆传媒: 6717c18650fda_PR-graphics-1920x1080-1.jpg

Cancer Research Institute Appoints New Chief Development and Operations Officers to Drive Growth and Innovation

CRI is proud to announce the appointment of Rachael Brown, Chief Development Officer, and Scott Glenn, Chief Operations Officer.
22-Oct-2024 12:20 PM EDT Add to Favorites

麻豆传媒: /images/uploads/2024/10/08/67055d5c3a57a_CRI-Gala-posts-1080x1080-1.jpg

Immunotherapy Titans to Be Honored for Scientific Excellence at CRI鈥檚 2024 Annual Awards Gala

CRI will honor Drs. O'Donnell-Tormey, Schietinger, Anderson, Benoist, and Mathis during its 2024 annual awards gala.
8-Oct-2024 12:45 PM EDT Add to Favorites

麻豆传媒: 66f2dc9f2cc65_CRIxKCAlogo.png

The Cancer Research Institute and the Kidney Cancer Association Announce a Collaboration to Co-Fund Kidney Cancer Immunotherapy Research

The Cancer Research Institute and the Kidney Cancer Association are collaborating on a new kidney cancer immunotherapy research grant.
24-Sep-2024 11:05 AM EDT Add to Favorites

麻豆传媒: 66df159e37f19_image3.png

Cancer Research Institute (CRI) Appoints Alicia Zhou, PhD, as Chief Executive Officer to Advance Next Generation of Cancer Immunotherapy Science and Innovation

The Cancer Research Institute (CRI) has appointed Alicia Zhou, PhD, as its new Chief Executive Officer (CEO).
9-Sep-2024 12:10 PM EDT Add to Favorites

麻豆传媒: 66da21ae5a5a9_4570198058921392262838588428744184134729690n-1.jpg

Global Experts Converge at CICON24 to Unveil Groundbreaking Advances in Cancer Immunotherapy, September 8-11, 2024 at National Harbor, MD

CRI is co-hosting CICON24 to illuminate pioneering advances in cancer immunotherapy research starting September 8 in National Harbor, MD.
6-Sep-2024 12:20 PM EDT Add to Favorites

麻豆传媒: 66b0eaaaca624_CRI-Logo-7-19-23.jpg

Cancer Research Institute Awards Over $22 Million in Grants to Fuel Immunotherapy Innovations

CRI awarded over $22 million to leading cancer immunotherapy researchers in the 2024 fiscal year, amounting to 64 awards at 42 institutions.
8-Aug-2024 10:00 AM EDT Add to Favorites

麻豆传媒: 66b0d19aaf19a_2024STARs.jpg

Cancer Research Institute Announces New Lloyd J. Old STARs Class

CRI has announced its new class of 2024 Scientists Taking Risks (STARs) grant recipients who are expert cancer immunotherapy researchers.
5-Aug-2024 11:00 AM EDT Add to Favorites

麻豆传媒: 65b11698dc984_1-24-24pressrelease.png

New Survey of U.S. Oncologists Reveals Where More Work Can Be Done to Research Treatments for Advanced Non-Small Cell Lung Cancer

CRI helped commission a poll of oncologists who say that much more research is required to holistically tackle non-small cell lung cancer.
24-Jan-2024 8:50 AM EST Add to Favorites


See All News

Our Experts on News

Expert Available for Commentary on Recent FDA Analysis of TNF Blockers

The FDA announced on Aug 4 2009 that tumor necrosis factor (TNF) blockers used in the treatment of immune disorders carry an increased risk of lymphoma and other cancers in children and adolescents. The discoverer of TNF-alpha, Lloyd J. Old, M.D., a...
7-Aug-2009 9:00 AM EDT

PROVENGE Cancer Vaccine Heralds New Dawn in Cancer Therapy

Dendreon's PROVENGE for the treatment of advanced prostate cancer is the first active cellular immunotherapy to prolong patient survival, according to data from a pivotal phase III clinical trial announced at yesterday's AUA annual meeting in...
29-Apr-2009 11:20 AM EDT

See All Experts

Our YouTube Videos
View All >

About

The mission of the Cancer Research Institute is to save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer.

Twitter

Facebook

close
0.27779